Coral Labs.

{
  "main_header": {
    "sid": 476417,
    "name": "Coral Labs.",
    "stock_name": "Coral Labs.",
    "full_name": "Coral Laboratories Ltd",
    "name_url": "stocks-analysis/coral-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "424.95",
    "chg": 3.85,
    "chgp": "0.91%",
    "dir": 1,
    "prev_price": "421.10",
    "mcapval": "152.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524506,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE683E01017",
    "curr_date": "Apr 30",
    "curr_time": "",
    "bse_nse_vol": "76 ",
    "exc_status": "Active",
    "traded_date": "Apr 30, 2026",
    "traded_date_str": "2026 04 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/coral-labs-476417-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Coral Laboratories Ltd Downgraded to Strong Sell Amid Deteriorating Technicals and Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-downgraded-to-strong-sell-amid-deteriorating-technicals-and-financials-3965872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CoralLaboratori_mojoScore_3965872.png",
        "date": "2026-04-28 08:28:43",
        "description": "Coral Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 27 Apr 2026. This revision reflects deteriorating technical indicators, poor financial performance, and subdued valuation metrics, signalling heightened risk for investors amid ongoing market challenges."
      },
      {
        "title": "Coral Laboratories Ltd Upgraded to Sell on Improving Valuation Despite Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-upgraded-to-sell-on-improving-valuation-despite-weak-financials-3953351",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CoralLaboratori_mojoScore_3953351.png",
        "date": "2026-04-20 08:12:07",
        "description": "Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 17 Apr 2026, reflecting a nuanced assessment across quality, valuation, financial trends, and technical parameters. Despite ongoing challenges in profitability and sales growth, the company’s valuation and debt profile have improved sufficiently to warrant a less severe rating, though caution remains warranted given recent performance."
      },
      {
        "title": "Coral Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-strong-sell-3941371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CoralLaboratori_mojoScore_3941371.png",
        "date": "2026-04-10 10:10:57",
        "description": "Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with the most recent and relevant data to assess the stock’s outlook."
      },
      {
        "title": "Coral Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-is-rated-strong-sell-3923691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_mojoScore_3923691.png",
        "date": "2026-03-30 10:10:44",
        "description": "Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-hits-52-week-low-amidst-continued-decline-3919608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3919608.png",
        "date": "2026-03-27 12:37:28",
        "description": ""
      },
      {
        "title": "Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-falls-to-52-week-low-amid-continued-downtrend-3916024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3916024.png",
        "date": "2026-03-25 10:43:27",
        "description": ""
      },
      {
        "title": "Coral Laboratories Ltd Falls to 52-Week Low of Rs 387.8 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-hits-52-week-low-amidst-continued-decline-3910282",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3910282.png",
        "date": "2026-03-24 11:14:06",
        "description": "For the third consecutive session, Coral Laboratories Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 387.8 on 24 Mar 2026. This marks a significant drop of 7.64% over the last three days, underscoring persistent selling pressure despite an intraday high of Rs 417 earlier today."
      },
      {
        "title": "Markets Rally, But Coral Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3906966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3906966.png",
        "date": "2026-03-23 10:24:26",
        "description": ""
      },
      {
        "title": "Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3895898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_mojoScore_3895898.png",
        "date": "2026-03-17 08:24:17",
        "description": "Coral Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 16 March 2026. This revision reflects deteriorating technical indicators, disappointing financial trends, and persistent valuation concerns, signalling heightened caution for investors amid ongoing underperformance relative to the broader market."
      }
    ],
    "total": 163,
    "sid": "476417",
    "stock_news_url": "https://www.marketsmojo.com/news/coral-laboratories-476417"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "30-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Coral Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24231MH1997PLC422233</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Diwakar Unnikrishna Menon <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: cs@corallab.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Sushma Kadkade <br/> Designation: Director and CFO <br/> EmailId: accounts@corallab.com</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Regarding Receipt Of Notice Under Section 18 Of MSMED Act 2006.",
      "datetime": "27-Apr-2026",
      "details": "Receipt of Notice under Section 18 of MSMED Act 2006",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Appointment Of Mr. Diwakar Unnikrishna Menon (ACS: 8791) As Company Secretary And Compliance Officer Of The Company",
      "datetime": "23-Apr-2026",
      "details": "Appointment of Mr. Diwakar Unnikrishna Menon (ACS: 8791) as Company Secretary and Compliance Officer of the Company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Coral Laboratories Ltd has declared <strong>15%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Coral Laboratories Ltd Downgraded to Strong Sell Amid Deteriorating Technicals and Financials

2026-04-28 08:28:43

Coral Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 27 Apr 2026. This revision reflects deteriorating technical indicators, poor financial performance, and subdued valuation metrics, signalling heightened risk for investors amid ongoing market challenges.

Read full news article

Coral Laboratories Ltd Upgraded to Sell on Improving Valuation Despite Weak Financials

2026-04-20 08:12:07

Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 17 Apr 2026, reflecting a nuanced assessment across quality, valuation, financial trends, and technical parameters. Despite ongoing challenges in profitability and sales growth, the company’s valuation and debt profile have improved sufficiently to warrant a less severe rating, though caution remains warranted given recent performance.

Read full news article

Coral Laboratories Ltd is Rated Strong Sell

2026-04-10 10:10:57

Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 April 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.

Read full news article

Coral Laboratories Ltd is Rated Strong Sell

2026-03-30 10:10:44

Coral Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 16 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low

2026-03-27 12:37:28

Read full news article

Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low

2026-03-25 10:43:27

Read full news article

Coral Laboratories Ltd Falls to 52-Week Low of Rs 387.8 as Sell-Off Deepens

2026-03-24 11:14:06

For the third consecutive session, Coral Laboratories Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 387.8 on 24 Mar 2026. This marks a significant drop of 7.64% over the last three days, underscoring persistent selling pressure despite an intraday high of Rs 417 earlier today.

Read full news article

Markets Rally, But Coral Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-23 10:24:26

Read full news article

Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-03-17 08:24:17

Coral Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 16 March 2026. This revision reflects deteriorating technical indicators, disappointing financial trends, and persistent valuation concerns, signalling heightened caution for investors amid ongoing underperformance relative to the broader market.

Read full news article

View All News